This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Wendy Broom, PhD
Director of Oncology at Codiak Biosciences


Wendy Broom currently directs the Oncology group at Codiak BioSciences, driving multiple programs through pre-clinical to clinical phase development utilizing their engX™ Platform. She is focused on the development of exosome based therapeutics for oncology and immune-oncology indications.

Agenda Sessions

  • Delivery of Antisense Oligonucleotide-loaded Exosome to Target Macrophage Reprogramming, Reduce the Immunosuppressive Tumor Microenvironment and Generate Potent Anti-tumor Efficacy

    On Demand
  • Discovery, Preclinical and Clinical Development of Oligonucleotides